Magnesium hydroxide and Levaquin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Magnesium hydroxide (magnesium) and Levaquin (levofloxacin). Common drug interactions include platelet count decreased among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Magnesium hydroxide and Levaquin. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Magnesium hydroxide?

Magnesium hydroxide has active ingredients of magnesium. eHealthMe is studying from 1,806 Magnesium hydroxide users. Check the latest studies of Magnesium hydroxide.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 28, 2026

25 people who take Magnesium hydroxide and Levaquin together, and have interactions are studied.

Magnesium hydroxide and Levaquin drug interactions.

What are the common drug interactions of Magnesium Hydroxide and Levaquin, by gender? *:

female:

  1. Platelet count decreased
  2. Pruritus (severe itching of the skin)
  3. Skin infection
  4. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  5. Fractured sacrum
  6. Infusion site scar
  7. Muscular weakness (muscle weakness)
  8. Pain in extremity
  9. Pelvic pain
  10. Urinary retention (the inability to completely or partially empty the bladder)

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Balance disorder
  3. Asthenia (weakness)
  4. Blood sodium decreased
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  7. Constipation
  8. Drug eruption (adverse drug reaction of the skin)
  9. Drug hypersensitivity
  10. Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Magnesium Hydroxide and Levaquin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Osteonecrosis (death of bone)
  2. Platelet count decreased
  3. Procedural pain
  4. Pulmonary function test decreased
  5. Pyrexia (fever)
  6. White blood cell count decreased
  7. Haematocrit decreased
  8. Haemoglobin decreased
  9. Red blood cell count decreased
  10. Total lung capacity decreased

20-29:

n/a

30-39:

n/a

40-49:

  1. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  2. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)

50-59:

  1. Chronic kidney disease
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

60+:

  1. Fall
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Arthritis infective (purulent invasion of a joint by an infectious agent which produces arthritis)
  4. Burning sensation
  5. Dehydration (dryness resulting from the removal of water)
  6. Feeling hot
  7. Fungal infection
  8. Fungal skin infection
  9. Gingivitis (inflammation of gums)
  10. Infusion site discomfort

What are the existing conditions these people have? *

  1. Pain: 8 people, 32.00%
  2. Nausea (feeling of having an urge to vomit): 6 people, 24.00%
  3. Multiple Myeloma (cancer of the plasma cells): 5 people, 20.00%
  4. High Blood Pressure: 5 people, 20.00%
  5. Immunodeficiency Common Variable: 5 people, 20.00%
  6. Dyspnea (difficult or laboured breathing): 5 people, 20.00%
  7. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 16.00%
  8. Constipation: 4 people, 16.00%
  9. Infection: 3 people, 12.00%
  10. Stress And Anxiety: 3 people, 12.00%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium hydroxide and Levaquin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Magnesium hydroxide and Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Magnesium hydroxide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Magnesium hydroxide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levaquin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on magnesium and levofloxacin (the active ingredients of Magnesium hydroxide and Levaquin, respectively), and Magnesium hydroxide and Levaquin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: